ARXXONT

Details for Australian Trade Mark No. 1047070 (hide)

Owner Eli Lilly and Company an Indiana corporation

Convention US 20 OCTOBER 2004 78/502675

Service Spruson & Ferguson

Various Convention priority claimed: 20 October 2004, United States of America, No. 78/502675 in respect of PHARMACEUTICAL P R E P A R A T I O N S , N A M E L Y P H A R M A C E U T I C A L P R E P A R A T I O N S F O R T H E T R E A T M E N T A N D P R E V E N T

Filing Date 21 March 2005

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases and d i s o r d e r s , m u s c u l o s k e l e t a l d i s o r d e r s , neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Event Publications

14 April 2005 Application filed

14 April 2005 Application Accepted

11 August 2005 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1047071-Datamatic

1047069-HUMAPEN LUXURA